Clark Estates’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Clark Estates's MRNA Position: Q1 2023 in Review
Clark Estates sold out of Moderna (MRNA) in Q1 2023, closing a stake of 28,000 shares — an estimated $5.03M sold.
Clark Estates first reported a position in MRNA in Q1 2022 and held it in 4 quarters. The position peaked at $5.03M in Q4 2022. 1,018 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.
- Clark Estates reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
- Clark Estates sold 28,000 Moderna shares in Q1 2023, an estimated $5.03M.
- Clark Estates first reported a position in Moderna in Q1 2022 and held it in 4 quarters.
- Clark Estates's Moderna position peaked at $5.03M in Q4 2022.
- 1,018 funds tracked by Wall St. Rank held Moderna as of Q1 2023.
Based on Clark Estates's 13F filing for Q1 2023, filed 12 May 2023.